{"slug":"companies","open_questions":[{"id":"open_question-companies-sonde-health-70825c19","title":"Multi-modal integration","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-can-fite-biopharma-347c4d34","title":"Parkinson's Program","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-can-fite-biopharma-61009db5","title":"Pipeline Expansion","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-tsumura-6c46e7ed","title":"International partnership","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-tsumura-fd99ba86","title":"IND submission for TJ-67","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-k-health-81d5003d","title":"Memory Assessment","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-shimmer-30221c46","title":"Precision medicine","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-fbfa141d","title":"Treatment response prediction","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-91611493","title":"Privacy-preserving analytics","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-b1bce14d","title":"Multi-institution collaboration","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-7a97e463","title":"Regulatory acceptance","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-050a24ff","title":"Subgroup analysis","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-dcc51fac","title":"Subtype-specific treatment","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-5f8b9897","title":"Care personalization","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-07967613","title":"Disparities identification","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-optum-1f4b9f73","title":"Equity-focused analytics","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-ginkgo-af1d89e2","title":"Partnership development","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-ginkgo-8fdb043c","title":"Internal programs","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-ginkgo-303deeeb","title":"AI integration","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-companies-nippon-shinyaku-ea9b8dd3","title":"Geographic Expansion","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5}],"open_questions_total":20,"knowledge_gaps":[],"gap_count":0,"landscape":null,"hypothesis_count":0,"personas":[{"id":"christof-koch","name":"Christof Koch","type":"debater","icon":"🌀","color":"#5c6bc0","debate_count":1},{"id":"rui-costa","name":"Rui Costa","type":"debater","icon":"🏃","color":"#ef5350","debate_count":1},{"id":"xiaojun-li","name":"Xiaojun Li","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"pete-skene","name":"Pete Skene","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"ed-lein","name":"Ed Lein","type":"debater","icon":"🧠","color":"#4fc3f7","debate_count":0},{"id":"clinical_trialist","name":"Clinical Trialist","type":"reviewer","icon":"📋","color":"#4dd0e1","debate_count":0},{"id":"sud-pinglay","name":"Sud Pinglay","type":"debater","icon":"🧬","color":"#26a69a","debate_count":0},{"id":"jay-shendure","name":"Jay Shendure","type":"debater","icon":"🧪","color":"#ffa726","debate_count":0},{"id":"medicinal_chemist","name":"Medicinal Chemist","type":"builder","icon":"🧪","color":"#aed581","debate_count":0}]}